Physician profile
John Werber
NPI 1417275520
$940.27
in general payments reported to CMS, 2019-2025
11 companies · $68.60 in 2025
The $68.60 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $14.99 · 2022: $169 · 2023: $273 · 2024: $141 · 2025: $68.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $483.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $325.94 | 2019-2022 | |
| Irhythm Technologies, INC. | $172.87 | 2023-2024 | Zio Xt Patch, Zio Monitor |
| Edwards Lifesciences Corporation | $156.93 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Novo Nordisk INC | $85.34 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $80.69 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $42.14 | 2024 | Optimizer |
| Abbott Laboratories | $23.38 | 2019 | |
| Scpharmaceuticals INC. | $20.59 | 2024 | |
| Pfizer INC. | $14.13 | 2019 | |
| Gilead Sciences, INC. | $13.59 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $4.67 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Werber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.